The short answer: Breast preservation is possible for many women with invasive lobular carcinoma (ILC). The key is careful imaging before surgery, clear surgical margins, and skilled surgical technique. Robotic and oncoplastic approaches may improve your chances of saving your breast while removing the cancer. Whether you are a candidate depends on tumor size, location, and how the cancer has spread.
What Is Invasive Lobular Carcinoma?
Invasive lobular carcinoma is the second most common type of breast cancer. It accounts for around 15% of all breast cancer diagnoses, according to Cancer Research UK. Despite being found in roughly one in seven women with breast cancer, ILC remains less well known than invasive ductal carcinoma (IDC), the more common type.
The key difference is how ILC grows. IDC tends to form a firm, distinct mass. ILC spreads in a diffuse, finger-like pattern through breast tissue - often described as cells moving in single-file lines. This pattern affects both detection and surgery.
ILC is most often estrogen-receptor positive and progesterone-receptor positive. This means hormone-blocking therapies are usually part of the treatment plan alongside surgery and radiotherapy.
Why ILC Behaves Differently - and Why That Changes Your Surgical Decision
Because ILC spreads diffusely rather than forming a clear mass, it can be harder to detect on standard mammography or ultrasound. Many women with ILC notice a thickening of the breast tissue rather than a hard lump. Others notice a change in the shape or size of the breast, puckering of the skin, or a swelling under the arm. Breast Cancer Now notes that ILC does not always produce the classic signs associated with other breast cancers, which is one reason it can be diagnosed at a later stage than IDC.
For surgery, the diffuse growth pattern means the boundaries of the cancer can be harder to define on imaging. It also means that during the operation, achieving clear margins (removing cancer cells with healthy tissue around them) can be more technically demanding than with IDC.
This does not make surgery unsafe. It does mean that imaging, planning, and technique matter more for ILC than for many other breast cancer types.
Why MRI Is Essential Before Surgery for ILC
Standard mammography tends to underestimate the true size of an ILC tumor. Breast MRI is currently the most accurate imaging tool for staging ILC before an operation. Research shows that breast MRI has a sensitivity of around 93% for detecting ILC - considerably higher than conventional mammography or ultrasound for this type.
The same imaging research found that MRI changed the planned operation in around 26 out of every 100 women (26.4%) with ILC. Without MRI, some women would go into surgery with an incomplete picture of how far the cancer had spread. This could result in incomplete removal or the need for further surgery later.
UK clinical guidelines recommend MRI for women with ILC who are being assessed for breast-conserving surgery. If you have been diagnosed with ILC and have not yet had a pre-operative breast MRI, it is worth raising this with your team as early as possible.
Can You Preserve Your Breast if You Have ILC?
For many women, the answer is yes - but candidacy depends on several factors.
Breast-conserving surgery - removing the tumor and a margin of surrounding tissue (lumpectomy), followed by radiotherapy - is an established treatment option for early-stage ILC. Evidence shows that long-term outcomes from breast conservation are broadly similar to mastectomy in carefully selected women, with no significant difference in overall survival when surgery is combined with radiotherapy and, where appropriate, endocrine therapy.
The challenge specific to ILC is the margin result. When surgeons perform a standard lumpectomy for ILC, the rate of positive margins - where cancer cells reach the edge of the removed tissue - ranges from 18% to 60% of cases, depending on technique and tumor characteristics. This is notably higher than with IDC and is one reason some surgeons have previously recommended mastectomy for women with ILC.
But that positive margin rate is not fixed. It reflects what standard lumpectomy achieves on its own. Oncoplastic and robotic techniques change this substantially. If you have been told that mastectomy is your only option, our guide on getting a second opinion on a mastectomy recommendation explains how to approach that conversation without disrupting your existing care.
How Oncoplastic and Robotic Techniques Improve Breast Conservation for ILC
Oncoplastic surgery combines cancer removal with plastic-surgery tissue reshaping at the same time. This allows the surgeon to remove a wider margin of tissue - reducing the risk of leaving cancer cells behind - while still achieving a good cosmetic result. The wider excision is what matters most for ILC.
A study from the National Institutes of Health compared outcomes for women with ILC who had standard lumpectomy against those who had immediate oncoplastic surgery. The results were clear:
- Standard lumpectomy: 73.9% rate of successful breast conservation
- Oncoplastic reduction mammoplasty: 87.8% rate of successful breast conservation
- Oncoplastic closure: 94.2% rate of successful breast conservation
The same study found no difference in recurrence-free survival between those who had oncoplastic surgery and those who had standard lumpectomy alone. Oncoplastic techniques improved the surgical result without compromising cancer safety.
Robotic-assisted surgery builds on these oncoplastic principles with additional precision. The robotic system provides a magnified, three-dimensional view of the surgical field. The instruments operate without tremor. Incisions can be placed in less visible locations - such as the armpit or the natural fold under the breast - which reduces visible scarring after surgery. For ILC, where margin precision is important, this level of surgical control may reduce the risk of incomplete excision. To understand whether this approach could apply to your situation, our guide on eligibility for robotic breast cancer surgery outlines the key candidacy factors in plain language.
How Does Breast Conservation Compare to Mastectomy for ILC?
| Factor | Breast-Conserving Surgery (Lumpectomy + Radiotherapy) | Mastectomy |
|---|---|---|
| Typical eligibility | Early-stage ILC; tumor-to-breast ratio suitable for wide excision; single focus confirmed on MRI; no BRCA indication for bilateral surgery | Larger or multifocal or multicentric ILC; conservation not achievable; patient preference; BRCA gene change present |
| Positive margin risk | 18%-60% with standard lumpectomy; significantly lower with oncoplastic or robotic techniques (source: NIH 2024) | Lower risk of incomplete removal; margins more predictable with full breast removal |
| Local recurrence (with full treatment) | Estimated 3.5% at 5 years with lumpectomy plus radiotherapy and endocrine therapy (source: NIH 2023) | Low local recurrence rate; residual risk depends on nodal staging and systemic therapy received |
| Breast preservation | Yes - breast tissue retained; annual imaging of the treated breast required long-term | No - breast tissue removed; reconstruction (immediate or delayed) may be an option |
| Recovery and further treatment | Shorter initial surgical recovery; followed by a radiotherapy course (typically 3-6 weeks); endocrine therapy ongoing for most women | Longer initial surgical recovery, especially with reconstruction; radiotherapy may not be required depending on staging and nodal status |
The table highlights a key point for ILC: the gap between conservation and mastectomy in terms of positive margin risk is largely a question of surgical technique, not cancer biology. The difference between 73.9% and 94.2% breast conservation success comes down entirely to how the operation is performed. Asking your surgical team specifically whether oncoplastic or robotic techniques are available is a reasonable and important question before any decision is made.
When Mastectomy May Still Be the Right Choice for ILC
Breast conservation is not the right answer for every woman with ILC. Mastectomy may be the safer or more appropriate option if:
- The cancer is large relative to the size of the breast, making a cosmetically acceptable conservation impractical
- The ILC is multifocal (present in more than one area of the breast) or multicentric (involving more than one quadrant) - something that MRI is better placed to reveal before surgery
- Clear margins cannot be achieved even after re-excision
- A BRCA gene change is present, which may make prophylactic removal a more appropriate consideration
- You simply feel more comfortable knowing the breast has been fully removed
If mastectomy becomes the recommended route, the conversation then moves to reconstruction timing and technique. Our article on recurrence risk after robotic lumpectomy vs mastectomy covers the long-term evidence across both paths, which may help you weigh your options.
What Happens If Margins Are Not Clear After Lumpectomy?
If a lumpectomy for ILC returns positive margins, re-excision is often the next step before considering mastectomy. Research from the National Institutes of Health found that re-excision lumpectomy successfully cleared margins in approximately 74% of cases for ILC. If re-excision also results in positive margins, conversion to mastectomy may then be recommended.
Good pre-operative planning from the start - a full MRI, an experienced surgical team, and oncoplastic or robotic technique - reduces the likelihood of needing re-excision in the first place. This is one of the strongest arguments for seeking a surgeon with specific experience in ILC and oncoplastic or robotic breast conservation before the first operation, not after a difficult margin result.
UK Wait Times, Private Access, and Travelling to India for ILC Surgery
In the NHS, the pathway from ILC diagnosis through surgical assessment to the operation itself can span several months. For a cancer type where pre-operative MRI and a carefully planned surgical approach are particularly important, this wait is difficult to manage both emotionally and practically.
Private care in the UK can shorten wait times but adds significant cost. Oncoplastic and robotic breast surgery expertise for ILC specifically is concentrated in a small number of centres, and not every UK private hospital offers both the imaging and the surgical skill set needed for this cancer type.
Some UK women are now travelling to India for robotic and oncoplastic breast surgery. Specialist centres in India operate the same robotic surgical platforms used in leading UK and US hospitals. Wait times are typically shorter. Costs are substantially lower than UK private rates. Many hospitals offer female surgeons and female patient coordinators for women who prefer an all-female care team. If you are weighing your NHS timeline or UK private plan against seeking specialist care elsewhere, you can consult the Art of Healing Cancer team before committing to a UK surgical plan. They can review your imaging and surgical recommendation confidentially and advise on whether international options merit further exploration for your specific case.
When to Talk to Your Doctor
Speak to your surgical team as a priority if:
- You have been diagnosed with ILC and have not yet had a pre-operative breast MRI as part of your surgical planning
- You have been recommended mastectomy and want to understand whether oncoplastic or robotic breast-conserving surgery might be an option in your case
- You have had a lumpectomy for ILC and positive margins are being discussed, including the possibility of re-excision or conversion to mastectomy
- You are considering a second opinion before committing to any surgical plan
If you would like to explore your options with a specialist team experienced in robotic breast surgery for ILC, you can submit an enquiry at BreastCancer.One. Coordinators are available to support you through the process.
This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.